Compare Cigna Corp (CI) vs Coupang Inc (CPNG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs Coupang Inc — how do they compare? Cigna Corp trades at $274.26 (market cap $73.56B), while Coupang Inc trades at $16.42 (market cap $29.66B). The key difference: Cigna Corp is far larger — about 2.5× Coupang Inc's market cap, and Cigna Corp pays a 2.24% dividend while Coupang Inc pays none. Which is the better fit depends on your goals.
| CI | CPNG | |
|---|---|---|
Market Cap | $73.56B | $29.66B |
Sector | Health | Consumer Cyclical |
52-Week High | $311.00 | $33.53 |
52-Week Low | $244.41 | $15.12 |
Enterprise Value | $98.27B | $29.18B |
Dividend Yield | 2.24% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $278.40, down 1.45% on the day, with a bearish technical signal but strong fundamentals including a P/E of 11.51 and ROE of 15.49%. Recent Q2 2026 earnings beat expectations at $7.78 per share, and the company raised its full-year EPS guidance. The stock is supported by consistent dividend payments and robust cash flow from operations of $9.60 billion in 2025.
The outlook is positive with a consensus price target of $338.90, implying 22% upside. Key opportunities include steady earnings growth and capital returns, while risks involve healthcare cost pressures and competitive dynamics. Analyst sentiment is strongly bullish with 73.68% buy ratings, though technical indicators suggest near-term caution.
CPNG trades at $16.19, down 0.25% on the day, with a bearish technical signal and recent earnings misses. Revenue grew to $34.53B in 2025, but net income margin remains thin at 0.6%. The stock is undervalued on a P/S basis at 0.85, yet high P/E and EV/EBITDA ratios reflect profitability challenges. Analyst consensus is strongly bullish with an average price target of $23.38, suggesting significant upside. Recent news highlights recovery from a data breach and expansion in Taiwan, though a $422M fine in South Korea poses regulatory risks.
The outlook hinges on execution in new markets and margin improvement. Upside potential exists if CPNG meets growth targets and reverses recent earnings underperformance, but investors face risks from competitive pressures, regulatory scrutiny, and volatile cash flows. The stock's current discount to analyst targets presents a opportunity, but sustained profitability is key to unlocking value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About Coupang Inc
Coupang Inc is an e-commerce company. The company sells apparel, electronics, footwear, food products, furniture, nutritional supplements, and other products. Its segments include Product Commerce and Growth Initiatives.
Read more on CPNG →
